Skip to main content

SPRB- Spruce Biosciences, Inc.

Spruce Biosciences, Inc. (SPRB) has 12 insiders with recent SEC Form 4 filings, including 4 buys and 10 sells. SPRB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO
Szwarcberg Javier B.
19.0K$882.2K-
Other13.0K$603.5K-
CFO
Gharib Samir M.
8.3K$383.6K-
Dir3.4K$157.8K-
CEO1.5K$68.7K-

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Oct 6, 2025Parkman Healthcare Partners LLC10% OwnerSell257$19.14$4,920.12-10.8%-37.0%-
Oct 6, 2025Parkman Healthcare Partners LLC10% OwnerSell257$19.14$4,920.12-10.8%-37.0%-
Oct 6, 2025Parkman Healthcare Partners LLC10% OwnerBuy256$17.91$4,585.16+24.4%-37.0%-
Oct 6, 2025Parkman Healthcare Partners LLC10% OwnerBuy256$17.91$4,585.16+24.4%-37.0%-
Mar 21, 2024Novo Holdings A/s5810% OwnerSell465,021$0.75$350,951.35-15.4%-29.9%-55.4%
Mar 20, 2024Novo Holdings A/s5810% OwnerSell1,794,999$0.76$1,358,803.76-14.8%-15.4%-54.9%
Mar 14, 2024Novo Holdings A/s5810% OwnerSell1,912,316$0.89$1,698,901.53-28.4%-18.0%-58.7%
Feb 16, 2023Novo Holdings A/s5810% OwnerBuy2,208,000$3.17$6,999,360.00+48.9%-8.4%+100.0%
Feb 16, 2023O'Donnell NiallDirectorBuy630,400$3.17$1,998,368.00+90.6%-8.4%+100.0%
May 20, 2021Simpson Camilla VDirectorSale+OE334$15.29$5,106.86-100%-46.2%-91.1%
Page 1Next →